Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000188874 | SCV000242504 | uncertain significance | not provided | 2020-01-15 | criteria provided, single submitter | clinical testing | The majority of missense variants in this gene are considered pathogenic (Stenson et al., 2014); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Substitution is predicted to be in the cytoplasmic loop between the first and second homologous domains; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 31780880) |
Neuro |
RCV000585879 | SCV000693813 | uncertain significance | Severe myoclonic epilepsy in infancy | 2018-01-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001857646 | SCV002133671 | likely benign | Early infantile epileptic encephalopathy with suppression bursts | 2024-09-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002399702 | SCV002707905 | uncertain significance | Inborn genetic diseases | 2021-07-14 | criteria provided, single submitter | clinical testing | Fernández-Marmiesse, 2019 Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |